Biliary excretion of iodipamide and iodoxamate in dogs with hepatic dysfunction induced by oral administration of dimethylnitrosamine.
Iodipamide and iodoxamate were compared in equimolar clinical dosages in five cholecystectomized chronic bile fistula dogs in which hepatic dysfunction was produced by oral administration of a total dose of 480 and 960 microliters dimethylnitrosamine  (DMNA), respectively. After both DMNA dosages, the peak biliary excretion rate for iodoxamate was significantly higher than for iodipamide (p less than 0.01). The peak bile iodine concentration was not significantly different for the two agents (480 microliter DMNA: p less than 0.1; 960 microliter DMNA: p = 0.07). On the basis of this investigation, it is suggested that iodoxamate should not significantly improve the opacification of the biliary system in patients with hepatic dysfunction.
D000818:Animals; D001646:Bile / Q000378:metabolism; D001652:Bile Ducts / Q000378:metabolism*; D056486:Chemical and Drug Induced Liver Injury; D002758:Cholangiography; D004128:Dimethylnitrosamine; D004285:Dogs; D007458:Iodipamide / Q000378:metabolism* / Q000652:urine; D007463:Iodobenzoates / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism* / Q000473:pathology; D008297:Male; D013997:Time Factors; D014283:Triiodobenzoic Acids / Q000378:metabolism* / Q000652:urine
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D004128:Dimethylnitrosamine; D007458:Iodipamide